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INTRODUCTION
The use of anthelmintic agents to control parasite damage in domestic
animals probably originated in ancient times. The need for combating hel-
minth infections was recognized long before it was possible to accurately
evaluate the more covert Implications of host-parasite relationships. Oer-
tainly, the dearth of effective antiparasitic substances during the past has
limited the extent to which many animal diseases could be controlled*
In recent years, the synthesis of many new chemical compounds has made
available a much larger selection of drugs with anthelmintic potentialities.
An important part of the applied research in the field of parasitology has
been directed toward the testing of these compounds with the use of experimen-
tal animals maintained under controlled laboratory conditions. Various as-
pects of Ascaridia ,^alli infections in chickens have received considerable
attention from a number of workers. At the present tine, nicotine compounds
are considered to be the drug of choice for this nematode. However, Hansen
et al, (195^0 showed that, while this compound was effective at some levels
in removing adults and the older larval stages, it was relatively ineffective
against the young migratory larvae. Since the studies of Ackert (1925),
Guberlet (1924), Ackert and Herrick (1926) and Todd et al. (l?49b) had indi-
cated that the greatest host injury due to A, galli was incurred during the
first 21 days after infection with embryonated ova, the primary objective of
this study was to determine the effect of several anthelmintics on this para-
site during this deleterious larval period in its life cycle.
KTIStf OP LITERATURE
The u8e of compounds of piperazlne as anthelmintics was first reported
in 1947. At that time, as the result of extensive screening of a variety of
drugs In the search for an effective antlfilarial agent* the relative effec-
tiveness of the compound was originally recognised* The search for such a
substance had been initiated during World War II, when the necessity for nsain-
tainlng our armed forces in endemic areas had emphasized the lack of a suit-
able compound for use in human filariasis (Kane-is, 1948), Among the major
studies concerning piperazlne were those of Hewitt and his associates (1947*,
1947b, 1947c, 1948a, 1948b) in which they experimentally evaluated the anti-
parasitic action of approximately 6f piperazlne compounds, using the ootton
rat and the dog as laboratory hosts. As a result of these tests, 49 of the
compounds tested were found to have no filaricidal activity, and further test-
ing of then was abandoned, Eighteen of the piperazlne derivatives showed seme
degree of anthelmintic activity? of these, l-carbethoxy-4-methylpiperazine
was effective against microfilariae of Litomoaoides carinjll in the cotton rat.
However, In other experiments against Dlrofllarla Jfealtla infections in dogs,
the drug was found to be toxic at effective levels. The symptoms shown by
the treated dogs were nausea, muscular weakness, salivation, and prostration,
A closely rolated substance, l-diethylcarbamyl-4-taethylplperazinc dihydrogen
citrate*, appeared to be more promising, not only because of its effectiveness
in removing worms, but also because of its lower toxicity.
As a result of these preliminary studies, further research was undertaken
on the toxicological, chemical, and pharmacological properties of certain of
*Ooamercially available from Lederle Laboratories Division, American
Cyanamld Company, as Hetrazan or Caricide,
the more promising piperazina compounds, Kuahner (1948) reported on the
chemical structure of the piperazines in general, and attempted to relate
their molecular structure with their efficiency as chemotherapeutic agents*
Harned et al, (1948a, b) studied the pharmacodynamic aspects of Retrazan,
The chemical preparation of piporazine derivatives T/as described by Stewart
et al. (1948).
Subsequent to the preliminary laboratory trials in which the effectiveness
of Retrazan was demonstrated for filarial infections in the cotton rat and the
dog, further test? irere conducted which indicated ite probable application in
the treatment of a variety of helminth infections in other hosts, Hewitt et
al, (1948b) successfully treated doge experimentally infected with ascarids,
and Kanegis (1948) reported similar results after treating ftsearjs-lnfeote
d
cats m p with Oaricide, Both papers reported that the drug approached
100 per cent efficacy in worm removal when administered at therapeutic levels.
In another study, Oliver-Gonzalez and Hewitt (1947) investigated its effec-
tiveness against trichinosis in white rats, Oolglazier and Susie (1951) ob-
served that Oaricide removed 98 per cent of the ascarids from 11 cats which
they treated, Guilhon and Groulade (1951), working with Tp:racara canje and
2» ^ystaj; infections in dogs and a cat, respectively, found that Retrazan
treatments at optimum dosage levels were effective in reducing fecal egg
counts. In a comprehensive study, Brown et al, (19^4) evaluated the activity
of 32 piperazine compounds against ftyphacia pbvelata, a mouse pinworm. Their
rosalts with Retrazan indicated that it was ineffective against Syphacift in
doses of 2J30 mgm/kg host body weight for two days. In another study, Guilhon
(1951) described his work on experimental infections of Agoarl.dia oolumbae in
pigeons. He found a complete absence of eggs in the feces resulted after
repeated doses of a jJ-5 per cent sugar solution of piperazine.
The use of Oaricide as a treatment for Ascarldia galli, the large intes-
tinal roundworm of the fowl, lias been reported two different times in the
literature, (Table 1), In 195G, Rledsl published the reeults of a study
froca which he concluded that a low level of anthelmintic efficiency in
addition to substantial host toxicity rendered Oaricide undesirable for treat-
ing 4» f&Mk infections in chickens. In one series of tects, 55 Rhode Island
Red Chickens were divided into three groups of approximately equal size. The
first group constituted an untreated control. The second :;roup was treated
once with 1 gm of Oaricide per bird, and Group III birds were given a 1 gm
dose, then redosed with 0,5 ga four hours later. Results were as follows*
Group I birds eliminated 0,75 per cent of their worms; Group II, 5^,5 per cent;
and Group III, 6£,4 per cent. There was no appreciable difference in average
weight gained per chicken in any of the three groups. In another series of
tests in which dosages and related treatment techniques were varied, the best
results were obtained by using a large initial dose of Oaricide followed by a
four hour fast, then a second dose of Oaricide, with a purgative added to the
feed after treatment, Ikmever, this treatment regime was considered unsatis-
factory due to a narked weight loss sustained by the treated birds coupled
with poor results in removal of worms*
The erratic results obtained in these earlier tests with single and
double dose treatments administered individually prompted Riedel (1951) to
study Oaricide 1* anthelmintic effect when added to the feed mixture of test
birds for an e:ctended period of time. The drug was added in proportions of
0,25 per cent, 0,5 per cent, 1,0 per cent, and 2,0 per cent to the feed of
four groups of chickens for seven consecutive days. Reduction in worm burden
resulting from this type of treatment was as follows* those birds receiving
0,25 per cent Oaricide feod ration eliminated 12,0 per cent of the Aacarldia
5harbored^ those given 0.5 per cent eliminated 28.6 per cent? thoso birds on
the 1,0 per cent mixture passed 50.0 per cent of their worms j and a 2.0 ^ar
cent concentration was 81.0 per cent effective in reducing worn numbers. The
level of infection remained constant in a group of control birds.
In another test in which JO heavily infected chickens reoeived a feed
mixture containing 1 per cent Oarioide for a two-week period and were purged
with Epsom Salts at the end of the first and second weeks, 89»2 -per cent of
the worms wore removed. In JO unpurged but otherwise similarly troated birds
the percentage of worn reduction was 72* In 15 untreated and unpurged controls
the percentage of infection remained constant.
Concurrent with the recognition of the potential value of Oarlcide as an
anthelmintic in certain animals, investigations were undertaken to evaluate
its application to helminth infections in man. Santiago-Stevenson et al.
(1947) reported a high rate of worm removal after treating six aecarld-in-
fected patients with Hetraaan. On the other hand, Oolbouroe (1950) considered
the results that he obtained with Hetrazan in treating 24 cases of ascariasis
to be unsuccessful. In 24 additional cases whioh were treated with Oil of
Chenopodiua, he obtained a higher rate of cure. Etteldorf and Crawford (1950)
published the results of a clinical study on the value of Hetraaan in treating
children for ftscaria lumbrlcoides, Coroos ct al. (1951) reported a complete
cure in 20 of 22 oases of ascariasis, and concluded that Hetrazan was partic-
ularly effective against that type of infeotion. similarly, Loughlin et al.
(1951) eotimated that Hetrazan had aohieved a 91-94 per cent reduction in
^goaris infections in their patients. Hoekenga (1951) reported no toxic
effects with varying dosages of Hetrazan, but of 15 patients that had received
what he considered to be the optimum dosage three times a day for three days,
only 9 were cured. A later study of hie (1952) likewise indicated thie piper-
azine compound wa» ineffective in removinp: ascarids in man. However, Singh
et al, (1952), using fecal egg counts as an index of infection, found that
Hetrazan treatment reduced the number of ova in the feces of 7 infected
children by 96 per cent. Oolbourne (1952) reported skin irritation in 25 per
cent of the aecariasie cases which he treated with Hetrazan in syrup form.
In a preliminary report, Mojumdar and Biswas (1955) observed that an eight-
day treatment regime had resulted in worm removal in 5 of 6 patients, but
usually not until on or after the fifth day. While reporting toxic reactions
in many patients following the administration of Hetrazan at a dosage level of
10 mgm per kg of host body weight, Bruapt, and Sang (195*0 conoluded that it
was effective against £• lumbricojdes
.
Elsewhere in the literature, Qhanem
(195*0 reported that Hetrazan was not appreciably toxic to 125 patients with
which he worked. A cure in 7 of 10 cases of ascariasis was reported by
Basnuevo and Fontao (1954). Brown and Sterman (195*0 considered Hetrazan to
be highly effective against Ascaris lumbricoides when administered at speci-
fied dosage rates on seven consecutive days. Another worker, Blus-Gayet (195*0
reported cures in 16 of 20 cases of ascariasis after one treatment with Hetra-
zan, and in 2 more caaes following a second treatment.
The demonstration in recent years of the value of Hetraaan (Oaricide) as
a medloal and veterinary anthelmintic has been reported in numerous publica-
tions, seme of which have been cited in this review of literature. More re-
cently the attention of some workers in this field has been turned toward the
testing of other compounds of piperazine. Davies et al. (195**) tested some
forty piperazine derivatives for activity against ntaaatodes in various domes-
tic animals. Their most extensive work involved the jn vivo screening of
piperazine adipate in dogs, cats, pigs, equines, and poultry. Their report
of the effects of this compound In treating 109 cockerels infected vdth
Aaoaridla galli revealed that, when incorporated in the feed mixture, it was
97 per cent effective in worm removal. These treatments were carried on for
periods varying from one to throe days* Single dose treatments administered
orally by capsule varied in efficiency from 75 to 100 per cent. Leiper (1954)
reported that he was able to remove all of the Ascarls from experimental pigs
which he treated individually with polymeric piperazine-1-carbodithioie acid*
Pield testing of this drug was then carried out to check the apparent activity
dsssonstrated under artificial conditions in the laboratory. Results there
indicated that in a wet or dry mash feed mixture, at dosage levels of 100-150
"EtAe kocly weight, this drug resulted in 85-100 per cent reduction in egg
counts in tl: treated animals.
The use of piperaaine hydrate as a medicinal for ascariasis in man was
reported by White (195^). All three oases which he treated resulted in com-
plete disappearance of Ascarls ova from the feces.
The use of carbon disulfide for Ascaridia ralli infections in chickens
has been reported by Roberts (1957)» **»d by Knapp and Hansen (199*0« Roberts
treated three birds ranging In weight from one to two pounds with individual
oral doses of 0.5 ml of carbon disulfide in gelatin capsules. Treatment was
preceded by 17 hours of fasting. This procedure resulted in the removal of
85.7 per cent of the total worms harbored by the three birds, but was accom-
panied by definite toxic symptoms lasting up to five days after treatment.
The work of Knapp and Hansen (195^) consisted of four experiments with
a total of 155 artificially infected chickens. In each test carbon disulfide
was administered orally after a 12 hour fast, 0.5 ml of anthelmintic per
bird removed 88 per cent of the ascarids. However, this treated group showed
an average weight loss of 29.5 ga* Pe r chicken, after medication. A second
8group received 0.6 ml of carbon disulfide per chicken. This dosage was 100
per cent effective in worm removal, but resulted in 55*5 Por cent k°st na-
tality, and an average weight loss of 88.8 gms per chicken in those that
survived the test. A third dosage level of 0.15 »1 per chicken reduced ths
worm burden of the group by 65 per cent and a normal weight increase followed
treatment. In vitro tests with adult A t i ffolll indicated that f-seov/i carbon
disulfide in an enclosed tube was fatal to the test worms in doses as small
as 0.05 ml.
9Table 1. Previous expcrfcaental tests
inactions in chickens.
with Carieide for Ascaridia jMil
Kuaber of
Chickens Used
in Experiment
•
1
1
1
Oaricids i
Dosage t
1
Percentage !
of Worms j
Eliminated J
1
toxic 1
Symptoms :
t
Reference
1? gas (control) 0.75 none Riedel (1950)
20 1 ga/blri 56.5 host weight
retarded
20 1 go/bird, plus
0.5 gn rodose
69.4 host weight
retarded more
severely
«
5 1 ga/bird 15.5 host weight
retarded
somewhat
1
5 1 ga/bird after
overnight fast
8.2 1 •
5 1 gm/bird after
overnight fast,
then 0.5 gp per
bird 4 hrs. after
first . dose
7.5
a
5 1 ga/bird, then
0.5 ga/bird 4 hrs,
after first doss,
then KgS04 in feed
6 hrs* after second
dose
43.5
l
severe loss
of weight
•
40
40
40
0.2#
concen-
0.5095 tration
in feed
1.0JS for 1 week
12
28.6
50.0
none
none
none
Riedel (1951)
«
•
40 2,0* 81.0 none
40 5»<# unpalatable »
19 (control) — •
# 1J& for 2 weeks
with purge at end
of first and
second weeks
89.2 —> »
50 1% for two weeks 72.0 - I
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MATERIALS AND METHODS
Anthelmintics
In the present study the following three anthelmintics were usedt Cari-
cide or Hetrazan (l-dlet3Tylcarbamyl-4-methylplperazine dihydrogen citrate),
Compound 180-0 (l-carbethoxy-4-methylpiperazine hydrochloride), and carbon
disulfide. The Oaricide (Hetrazan) and Oompound 180-0 were obtained from the
Lederle Laboratories Division, American Cyanamid Company, Pearl River, N. T*
Oariclde was supplied in two format tablets, for the Individual treatment of
experimental animals j and as a dry powder, for addition to the teat birds'
feed ration* In all experiments, the drugs were administered per os . The
dosage level and method of administration varied from test to test, as follows!
In Tent 1, a single dosage of 25 mgm of Oaricide per bird was usedj in Test 2,
12,5 mgm of Oaricide was given in tablet form for eight consecutive day»|
Test 5, approximately 12,5 ragrn of Oaricide per bird, as a powder incorporated
in the feed mixture) Test 4, an aqueous solution of 25 mgm of Oompound 180-0
per bird for eight consecutive daysj and Test % a single dose of 0.05 ml of
carbon disulfide administered in No. 4 gelatin capsules* The capsules were
individually filled with reagent grade carbon disulfide with the aid of a
tuberculin syringe, and were stored at J8° F. until used* Dosage rates,
method of administration, and length of treatment with the various drugs tested
are sumnarized more completely in succeeding sections of this thesis.
Toxicity
Riedel (1950* 1951) has reported some toxic effects of Oaricide on chiek-
when administered at certain dosage levels. His work with birds averaging
750 to 1050 gas In weight indicated that single or double doses of 0*5 gn
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of Caricide per bird, or lees, had no detrimental effects on the host. How-
ever, single or repeated 1,0 go doses resulted in either a weight loss or
failure to make normal weight gains. Other observable symptoms were loss of
appetita, incoordination, droopy wings, mucoid droppings, snd listlessncss
in the treated birds. Autopsies of birds exhibiting these tendencies in some
oases revealed a dehydrated condition of the tissues, distended kidneys, and
the crop filled with mucus. Model's report on group treatment experiments
(1951) indicated that 0,25, 0»50, 1,0, and 2,0 per cent concentrations of
Caricide were palatable to eight-week old chicks, but that a 5 per cent mix-
ture was both toxic and unpalatable.
No visible toxic effects were noticeable in the present tests with Cari-
cide or Compound 180-C at the levels which were used. In some cases, however*
a slight initial decrease in feed consumption was noted in tests in which the
medication was mixed with the feed mash,
Roberts (1957) observed that considerable distress and lack of appetite
resulted following treatment of three 1,0 to 1,5 pound birds with 0.3 ml of
carbon disulfide. In the present experiment, some transient symptoms of
toxicity were evident immediately following the administration of 0,05 ^1 of
this compound. These symptoms included gasping, listlessness, and inactivity
for several hours subsequent to treatment, There were no permanent weight
losses resulting from treatment with any of the three anthelmintic substances.
Mode of Action
In seeking an explanation for the variability in anthelmintic efficacy
exhibited by Caricide (Retrazan) when used in a number of different host
species for a variety of parasitic infections, several factors must be con-
sidered. Most of them, admittedly, are merely speculative at the present
12
time. They may be considered under three broad categories t factors relating
to the host, factors relating to the parasite, and factors inherent in the
drug,
Within the first category might be included such variables among host
species as age, diet, body temperature, and general physiological variations
from one species to another. The potential role of natural and acquired im-
munity in host resistance to parasitism may play an important part in deter-
mining whether or not the host ultimately becomes infected. This applies to
experimental infections as trail as to those contracted through natural circum-
stances. The work of Ackert and his associates (1931a, 195*o> 1952, 1953a»
195Jb» 1955a* 1935b» 1955c) provides considerable evidence in support of this
idea. The combined influence of immunological factors, and of diet as indi-
cated by Hansen et al, (1955) b^ ke^-P *o explain the wide variation in infec-
tion within treated groups of experimental animals which received a constant
number of infective ova and equal amounts of an anthelmintic.
Under factors relating to the parasite, such variables as morphological
variation within the different species of ascarids, nutritional fluctuations,
and differences in life cycles should be considered. Worm size may be impor-
tant in that it would influence the amount of surface area which would be
exposed to the toxic action of the anthelmintic. In previous studies Hotrazan
therapy was directed against adult Asparis lijmbriooides residing in the lumen
of the host's intestine, whereas, the present tests were directed against
Ascaridia larvae during a stage of their life cycle in which they were partial-
ly Imbedded in the mucosa of the intestine. This habitat would seem to render
the parasite less accessible to the action of the anthelmintic. In the in-
stances where Hetrazan was tested against filarial \«>rme, the parasite was
located in the circulatory or lymphatic system of the host, and the action of
15
the drug depended, among other things, upon its absorbtion Into the circula-
tion* Hetrazan is highly soluble in water (Earned et al„, 1948a, b), which
may partially account for its proven effectiveness against filarial parasites
•
Iiikowise, a high degree of solubility may also contribute to its lack of
ability to act against worms whose habitat is the lumen of the intestine*
Accordingly, a relatively insoluble compound would remain longer and exert a
prolonged toxic effect on the worms in that situation (Chopra and Chandler,
1928), This idea was also propounded by Hall and Shillinger (1924), after
tests of a large number of anthelmintics* They reported that an increase In
drug solubility was almost always accompanied by a diminished anthelmintic
efficacy* Woodruff (1951), by comparing liver biopsies made before and after
Hetrazan treatment for Loiasls, concluded that the microfilariae of this nema-
tode were removed from the blood stream and phagocytlsed in the liver as a
result of this therapy. Johri (1953)* while investigating the effect of
Hetrazan on Aj. lveabricoides in children, found that treatment resulted in
paralysis of those worms which were expelled.
Among the factors inherent in the nature of the drug that might influ-
ence its mode of action would be its chemical properties, and such physical
characteristics as solubility, volatility, and osmotic properties, Cariclde
is known chemically as l-diethylcarbamyl«-4-«ethylpiperazine dihydrogen citrate,
and its structure is represented graphically as follows!
HC1 • X N C N
14
After conducting |n vlyp tests in cotton rats and dogs, Hewitt et al.
(1947a, o, c) stated that the plperasstee nucleus alone showed no anthelmintic
activity, therefore, at least against those paraoitee for which he conducted
tests, the activity appears to be due to the side chain groups attached to
the nucleus* That the HC1 group (located in Caricide on the end of the chain
attached to position 1) may be of some importance has been postulated by
several workers. Caius and Mhaskar (192J), in attempting to correlate the
chemical composition and therapeutic value of come anti-hookworm drugs, ob-
served that the value of carbon tetrachloride was related to the emulative
effect of the halogen fraction of the compound. Hall and Shilllnger (1924)
stated that the apparent efficacy of both carbon tetrachloride and ethylene
dlchloride was due to their halogen concentration. Likewise, Wright and
Sohaffer (1952 ) observed that as the halogen content of certain drugs Increased,
so increased the anthelmintic efficacy,
A further indication that the anthelmintic activity of Caricide resides
in the side chain is found in work reported by Doak and Bagle (1951). In
correlating the chemical structure and biological activity of some arsenoben-
aenes, they reported that the activity and toxicity of the substituted com-
pounds tested depended i$>on the nature of the terminal groupings of the side
chains. The length of the chains did not influence their anthelmintic activ-
ity.
Available experimental evidence, therefore, seems to indicate that the
effectiveness of Hetrasan (Caricide) for same types of parasitic infection is
due in part to its high solubility, and to the presence of the side chain
terminating in a halogen compound.
15
Experimental Animals
The chickens used in the tests were obtained from an approved commercial
hatchery as non-sexed day old birds. This precluded the likelihood of any
outside source of Ascaridja infection. White Rocks were used in the Oaricide
experiments, and New Hampshirea in Tests 4 and 5* On receipt at the labora-
tory, the chicks were vaccinated ( intranasal ly, or with an additive in the
drinking water) for Newcastle** disease, and were placed in electrically
heated brooder batteries. At fourteen days of age they were weighed, wing*
banded, and divided into groups of approximately equal weight by the technique
of Gardiner and Hehr (1950)* This facilitated maintaining the different
groups of birds on approximately equal daily rations of food and water. A
standard cooraercial feed in mash and pellet form was used in the first two
testa, and a mash-type ration exclusively in the remaining work. After the
chicks were experimentally infected, daily records were kept of their weights
in grams. An attempt was made to weigh the birds at about the same time eaoh
day, so as to obtain an accurate indication of the day-to-day gaina.
Infeotion Technique
In all five tests, the method of preparing Ascaridia egg cultures was
similar to that described by Ackert (in Needham et al«, 1931 1 P# 171 )• This
technique consisted essentially of exoising the anterior end of live female
ascarids, and withdrawing the internal organs from the worm. After separating
the uteri from the other viscera, only the portion of the uterus proximal to
the genital pore was retained as an egg source* This seemed to increase the
proportion of viable ova. These uterine sections were transferred to a petri
dish filled with tap water, and the uteri dissected to allow the eggs to
16
spread out Into the water. The covered petri dishes containing the egg cul-
tures were maintained in a standard laboratory Incubator at 28° 0. for at
least two weeks before being used. All cultures older than four weeks were
considered to hare passed the point of maximun viability, and were discarded.
A variation in the Ackert technique for preparation of ova for incubation was
followed in Test 4. After separation of the uteri from the worm in the usual
manner, an artificial digestive juice containing 0,5 per cent HCl and 1 per
cent pepsin was used to remove the remnants of uteri from the culture fluid*
Since this digestion process removed immature eggs as well as uterine remnants
(Hansen et al, 1954b), it facilitated the preparation of cultures with a high
percentage of viable ova. Following incubation, the preparation of a stock
solution of Ascaridja ova for administration to the chickens was patterned
after another technique developed by Hansen et al. Prom the egg culture a
random quantity of incubated ova was pipetted into a straight-sided shell
vial containing 15 ml of water. After thoroughly agitating this suspension,
one drop of fluid was removed with a calibrated pipette and examined under a
compound microscope. When the addition of sufficient ova from the original
culture to the shell vial had resulted in a count of 55 embryonated ova per
drop of stock fluid from the vial, enough sucrose was added to the 15 ml egg
suspension to form a 1,25 Molar solution. A sugar solution of this concen-
tration gave the most permanent egg suspension in the tests conducted by
Hansen et al. Their work in this connection had indicated that a water-egg
suspension method of administering Ascaridja ova tended to result in an
increase in the eggs per dose as the voluae of the suspension decreased. Sugar-
egg suspensions, in their tests, resulted in a relatively constant rate of In-
fection regardless of the order in which the birds were infected. The same
pipette was used for administering the infective ova to the birds that had
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been need in preparing the stock solution. As an additional precaution to
prevent any bias that might haw arisen in spite of this infection technique,
administration of the ova was alternated from a treated to an untreated
group of birds, All infective eggs were given per oa, in doses of either
75 i. 5 or 100 £ 10 infective ova.
Recovering Worms
In each experiment, the chickens were infected at fourteen days of age*
From that point, two variations were followed in test procedure. In Tests 1,
2, and J, "two treated (Group A) and two Infected but untreated (Group 8) birds
were sacrificed every 2k hours from the eleventh day post-infection until day
25 post-infection. This procedure was followed to test the action of the
anthelmintic during the progression of the tissue phase in the Asoaridla life
cycle. The pioneer work of Ackert (192J) on the life history of this worm
established the fact that it went through a semi-migratory stage later desig-
nated as the "tissue phase", during which it buried its head in the mucosa of
the intestine. Ackert and Berriek (1928), after additional work, discovered
that the time at which the most Injury to the host resulted was centored on
about the fourteenth day aftor experimental infection. Ackert et al. later
(1951) more definitely delimited this tissue phase as extending from the tenth
to the seventeenth day after infection.
On the twenty-fifth day poet-infection, an entire group of treated
(Groins 0) and an equal nuaber of control birds (Group D) were sacrificed.
This procedure was established to ascertain the effect of the anthelmintic
on the post ticsue phase larvae which at that time theoretically would be
located in the ltsaen of the small intestine.
The alternative experimental schedule carried out in Tests 4 and 5 was
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followed as a result of information acquired during the earlier experiments.
After reports of the first three tests were tabulated, it was evident that
any signifioant activity of the anthelmintic being tested had been best in-
dicated by the results obtained in Groups C and D, and that the information
theretofore obtained from Groups A and B had been quite limited* Therefore,
in Tests 4 and 5» the use of experimental groups A and B was tentatively
eliminated, until the activity of the anthelmintic on the later stages of
the larvae could be evaluated* Thus, only one treated and one control group
of chickens were utilized in the last two tests. All birds were sacrificed
twenty-one days after infection.
The methods employed in autopsying chickens to enumerate their worm bur-
den were essentially the sane as those described by Hansen et al, (195*to)«
A longitudinal incision was made through the abdominal wall of freshly killed
birds. Through this opening the portion of the small intestine extending
from the gizzard posteriorly to the remnant of the yolk sac diverticulum was
excised with scissors and removed to a pint glass jar. (Ackert, 19J1, con-
sidered this region to be the usual habitat of &. palll) . The removal of
worms contained within the intestinal sections was then accomplished by the
flushing technique described by Ackert and Holf (1?2Q), VJater under pressure
from a rubber tube was directed into one end of the intestine through a small
nozzle. This flushing action resulted in the washing of all unattached
ascarlds (i.e., those free in the luaen) from the intestine into the glass
jar. In experiments 1, 2, and % in which a count of the tissue phase larvae
was desired, a second procedure was followed, after flushing. Each section
of intestine was cut into small pieces and placed in an individual quart
glass jar containing about 600 ml of artificial digestion medluta (0,5 per cent
HC1 and 1,0 per cent pepsin). This method for recovery of the tissue phase
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larvae of Ascaridja was originated by Tugwell and Ackert (1952). The ^ars
were then imaoreed in a water bath at 58° C. for about five to eight hours,
with continual agitation, A modification of the apparatus used by Hansen
et al. (1954c), with glass stirring rods driven electrically from rubber V-
bolts (Pig* 1) was utilized to facilitate the digestion process.
Pig, 1. Artificial digestion apparatus for recovering tissue phase larvae
of Asoaridia galli from the walls of chicken Intestines*
After digestion of the intestines was completed, the residue and digest-
ing fluid remaining in the container with the worms was removed in this man-
ner. The jars were removed from the water bath and were filled to the top
with water, thus diluting the fluid present. After a short v;ait to allow the
worms (which had a higher specific gravity than the detritus) to settle to
the bottom of the jar, a J-shaped glaas tube attached to an aspirator via*
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used to remove the stipe matant fluid from the top of the jar. Three or four
repetitions of this operation resulted in a clear, concentrated fluid con-
taining the larvae which had been Imbedded in the walls of the digested in-
testine. To both the flushed and digested specimen jars was added enough
10 per cent foraalin to precerve the worms.
Counting and Measuring Worms
In counting the number of ascarids recovered, a wide-field binocular
microscope was used to examine the contents of each jar. The preserving fluid
containing the worms was poured, ft little at a time, into a petri dish which
had a specially designed grid on the bottom dividing it into a series of mi-
croscope fields, A fine dissecting needle was used to transfer the worms re-
covered under the microscope to screw-cap specimen vials containing 10 per
cent formalin, A Veeder counter was used to record the number of ascarids as
they were recovered.
Since worm length was considered as one criterion of the effect of the
anthelmintic on worms exposed to it, measure -onts were taken of the lengths
of samples of all worms recovered. This was done with the aid of a Leltz
projection apparatus somewhat similar to a darkroom enlarger. The worms to
be measured were placed on a 2" X J" glass slide on a stage on which the lens
of the viewer was focused, A magnified image of the worm was then projected
onto a ground glass plate. Tracings of the enlarged images of the worms
were made on onionskin paper, at a magnification of eight times, A Dietsgen
planimoter was used to measure the length (in centimeters) of the traced
linos, and conversion of this number gave the actual worm length.
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X>ERIMEHTAL RESULTS
Teat 1
Sach treated bird In this test received a. single 25 mgo. dose of Caricide,
Beginning on the eleventh day aftur treatment, and continuing for ten days
thereafter, two Group A and two Group B chickens were killed for autopsy each
24 hours • Groups C and D were sacrificed on the eleventh day after treatment*
Results are recorded in Tables 2 and Jt and in Fig* 2,
An average of 2,2 tissue phase larvae and 8,6 luaon larvae were recovered
from Group A birds, and an average of 2,9 tissue phase' and 8,2 lumen larvae
from Group B chickens. No statistically significant1 differences existed be-
tween the numbers of worms recovered.
Group C birds contained, on the average, 9,05 lunen larvae, compared to
5,7 for Croup 3, This difference was not significant,
A random sample of worms recovered from Group A chickens indicated that
they averaged 0,55 °b in length, compared to an average length in the Group B
birds of 0,66 cm. However, in view of the fr.ct that the variation between
worm lengths from Group C and D hosts was not significant, the end effect of
the Test 1 Caricide dosage on worm length is still obscure.
The average terminal weight (i.e., the final weight before sacrifice) of
Group C chickens was 268.5 &**t cmpared to an average of 248,6 <>ms for Group
D birds. This variation was not significant.
A level of significance of 5 P°r cent or less was considered to be of
statistical significance in analyzing the data reported in this thesis.
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Table 2. Results of daily examination* of chickens receiving a eingl*
25 mgm dose of O&rielde and their untreated controls.
Group t Chicken t Number of Hays s Worms Recovered
t Hunber
1
1 Post-Infection 1
t When Sranined 1
Tissue ?Jiase
Number
t Lumen
» Ember * Length
596 11 18 18
624 11 4 24
606 12 4 7
615 12 6 11
645 15 6 •
595 15 5 5
620 14 12
616 14 5
A 599 15 4 18
(treated) 600 *5 4 | —
—
646 16 6
570 16
601 17
564 17 28
596 18
18
19
4
15
2
618 19
625 20 2
'
Tetali a 164
Average! 2.2 8.6 0.55 an
629 11 11 4
650 11 15 5?
611 12 2 8
658 12 6 • 22
578 1? 15 12
621 15 5 l
l554 14 2
617 14 19
B 592 15 1
I(Control) 565 15 5
675 16 1 10
S2
16
17 7
•
567 17 2
647 18 1 6
622 18 4
568 19 1
674 19 5
599 20 2
Total i 56 164
Averages 2.9 8.2 0.66 <sa
mTable J. Comparative data on weight gained after treatment and numbers and
a statistical estimate of the lengths of lumen \Larvae recovered
from a treated group of chickens and its untreatod control eleven
days after infection •
Group t Chicken Number t Weight Increase 1 Lunen Larvae Recovered
i * After Treatment s Huabor t Length
f : Date (Gas) i
i
550 161 12
555 128 8
55* I55 2
561 98 41
562 109 5
57<S 115 5
i 580 126 6
C 585 106 6
(Treated) «B6 140 5
605
6o4
152
107
10
8
609 112 4
610 125 1
625 119 18
652 142 1
644 104 14
64© 88 8
Total
i
2059 154
Average
i
121.1 9.05 0.24 em
551 102 10
557 6B 6
sg 77
96
5
1
569 160 4
575 110 8
575 116 1
582 150 7
(Control) 584 75 10
588 87 10
589 86 6
5^ 90 5
606 76 8
62? 12
655 54 1
641 102 1
650 110 5
Total* I652 96
Average
i
97.1 5.7 0.21 cm
f
/
260 /
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/
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1 /
1 /
f r
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r 1
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. 2. ic-narison of grovth curves of chickens recei
sir v\ doae of Carieide and tneir untreated cor
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Toot 2
The treatment schedule for this teat consisted of 12»5 *agm of Garicide
given for ei^it consecutive days beginning the fourth day post-infection.
Two Group A and two Group B birds wore killed each twenty-four hours over
a ten-day period beginning the eleventh day post-Infection. Groups and
were sacrificed the eleventh day after troatmeiit. Results are sutaaarlzed in
Tables 4 and % and in Pig, %
Group A birds contained an average of J»5 tissue phase larvae and 12,2
lumen larvae, while Group B birds were infected, on the average, with 4,J
tissue phase and 10,5 lumen larvae, Ho significant differences existed here.
Group C chickens were infected with an average of 6".2 lumen larvae ccsa*.
pared to 6,1 worms per bird in Group D, This difference was not significant,
Ascarids recovered from Group A hosts averaged 1,43 en in length, cot*,
pared to an average worn length of Q,J9 en in Group B birds. This variation
was significant at the 1 per cent level. Group C chickens carried worms that
averaged 1,0 on in length, compared to an average of 0,2$) cm in the chickens
comprising Group B, This degree of variation was also significant at the
1 per cent level.
Terminal weights of Group and Group D birds were ^0%& gms and 2p4,l
gras, respectively. No significant variation existed here.
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Table 4. Results of daily examinations of chickens receiving 12,5 sign of
Caricide for eight consecutive days and their untreated controls.
Group * Chicken 1 Number of Days * VJome Recovered
* Number s Poet-Infoction
1 When Examined
t Tissue Phase
« Number
f Lumen
t Number t t»en£th
755 11 12 40
702 11 9 #
759 12 6
755 12 5 25
751 15
s
16
75<5 3 10707 1 4
712 14 10
709 15 5
k 717 15 1
(Treated) 800 16 5 15
797 16 1 3
801 17 e 4
755 17 2
776 18
4719 16
Jg 19 1 4
699 19 1
706 20 4
766 20 5
Total
i
70 245
Average* 5.5 12.2 1,48 em
725
708
11
11
10
16
22
21
795
768
12
12 I
55
9
808
746
15
14
15
12 i
789
806 1
J
B
(Control) i751
750
745
§
16
16
17
1
5
1
2
715 17 2 20
761 18 1
i805 18 1
771 19 25
781 19 1
741 20 1
805 20 5
Totals 86 206
Average* 10.3 0.39 cm
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Table 5. Comparative data on vfoight gained after treatment and numbers and
a statistical estimate of the lengths of lumen larvae recovered
from a treated group of chickens and its untreated control twenty-
one days after infection.
Group t Chicken Ninber t Weight Increase t Lumen Larvae Recovered
t * After Treatment » : Fta f.-.r.-r * Length
i i Date (Cms) t
70? 125 1
704 108 17
705 7
8
145
6
707 4
7H 90 6
718 158
727 151 6
728 152 22
754 151 5
7^0 154 1
C 747 68 14
(Treated) 757 114 11
772 147 2
775 82 5
•
77C 150 7
780 166 7
782 174 7
786" 99
788 176 4
196 105 8
799 147 1
804 108 5
Total
t
2824 159
Average
t
128.5 6.5 1,00 cm
710 96 6
711
716
9?104 I
721
724 t 1511
725 125
726 124 8
752 108 9
757 128 4
742 102
D 750 121
(Control) 754 151 15
758 108 7
759 148
760 112 9
762 116 5
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Table 5. (Oont»)
Group t Chicken Umber t Weight Increase » Lumen Larvae Recovered
I t After Trcatsnenti Kuabor » Length
764 110
i774 1J0
775 141 5
791 105
1794 158
748 110 2
Total
i
2587 154
Average
;
117.5 6.1 0.2? en
>
/
/
/ M
290 / /
//
270
s
//
/ /
/ /
CO
250 V
i ////H /// /
O 230 //6^ ///
/ /
^ /21C r* /
"*?
- #w
/ /
VK
/ V 3roup C (Treated)
17 C 1 \ » » 1 i i i » l .12 3 b 5 Q 7 8 ? 10 11
.'S SUBSEQUENT TO TRSATMENT 1«ITH CAKI'JIl
oarison of growth curves of chickens receivim
Rgm of Caricide for eight consecutive days and their untreated
controls.
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Teat 5
A continuous daily low-level ioas.ro of Caricide at the rata of approxi-
mately 12.5 mgm per bird was added as a supplement to the feed of all treated
chickens in this test. Beginning the eleventh day after infection, two Group
A and two Group B birds were sacrificed each day, for ten days* Groups G and
D were sacrificed, in their entirety, on the twenty-first day after infection.
Results are recorded in Tables 6 and 7» and in Pig. 4.
The average infection in Group A birde was 1.2 tissue phase and 17.0
luaen larvao, compared to 2.5 tissue phase and 1J.1 lumen larvae for the
Group B chickens. These figures did not differ significantly.
Group C chickens carried an average worn burden of 7.3 luaen uoras,
while the Group D average was 17.1 worms per chicken. This difference in
infection was not significant j however, it approached significance at the 5
per cent level.
The lumen larvae recovered from Group A hosts averaged 0,40 era in length,
compared to an average worm length of 0.70 cm in the Group B birds. This
variation was significant at the 1 per cent level. Group C birds were in-
fected with lumen larvae averaging 1.7 cm, while those from Group D hosts
averaged 1.9 cm in length. This variation was of no significance at the
5 per cent level.
Terminal weights of Group birds averaged 220.8 gms, while those of
Group D averaged 188.0 gas. This degree of variation was of borderline
significance at the 5 per cent level.
nTable 6. Results of dailj' examinations of chickens receiving a continuous
daily low-level dosagc of Oaricide at the rate of approximately
12,5 mga per bird and their untreated controls •
Group t Chicken } Nunber of Days » Woras Recovered
t Huober 1 Poet-Infection » Tisr.uc Phase 1 Linen
t i Wher.1 Examined t dumber 1 J['lumber t Len/rth
878 11 1 59
880 11 5 27
872 12 5 21
906 12 1 11
888 15 1
871 15 1 10
897 14 1 1?
A 891 14 2 1
(Treated) 869 15 2 6
890 15 50
909 16 1 1
895 16 1 14
910 17 1 10
874 17 4
882 18 18
915 18 1 24
905 19 42
901 19 12
Total
i
21 506
Average! 1.2 17.0 0.40 cm
946 11 7 20
951 11 11 5
972 12 5 5
958 12 16 15
942 15 18
92J i
14
2 56
949
951 I
5
58
B 954 15 5
(Control) 925 15 29
950 16 9
974 16 1
927 17
!
8
975 17 8
952 18 4
965 18 15
967 19
975 19 5 1
Total 45 256
Average j 2.5 15.1 O.70 on
ja
Table 7. Comparative data on weight gained after treatment and numbers and
a statistical 1aotiaate of the lengths of lumen larvae recovered
freei a treated group of chickens and :Lts untreatedI control t'.renty-
days after infection.
Group * Chickon Nuaber » -ht Increase t Luaen Larvae Recovered
1 t After Treatment 1 Nucaber * Length
: : Date (Cms) t t
8*58 109 29
875 94 5
879 104 1
885 74 4
896* 150 4
896 80
C 900 102 2
(Treated) 902
907
908
912
915
918
919
90
114
70
74
97
108
78
1
17
25
12
5
1
Totals 1524 102
Average t
924
928
950
m
94.5
78
80
58
66
58
91
82
7.5
14
5
7
60
24
15
2
1.7 cm
D 955 42 1
(Control)
957
960
961
962
96$
969
970
971
84
44
56
97
61
46
77
42
44
1
52
20
1
5
18
2
41
Total
t
1152 290
Average 1 6VS.5 17.1 1.9 cm

Test 4
The anthelmintic used in this test was Compound 180-0, Each Group
bird received a daily dosage of 25 a^a, for eight consecutive days, begin-
ning the tenth day post-infection. Group D birds were held as infectedf
untreated controls. Both groups wera killed for autopsy twenty-one days
after infection. Tables 8 and 9 and Pig. 5 depict the data obtained in this
experiment.
The average nuaber of lumen larvae recovered was 2J.5 in Group 0, and
15.1 In Group D. This variation was of no statistical significance.
Randomly chosen ascarids removed from Group C hosts averaged 1.00 em
in length, while worms recovered from Group D birds were, on the average,
1.4 cm long. This variation was significant at the 1 per cent level.
Terminal weights attained by the treated chickens averaged 256. 1 gns,
while for the untreated birds the average was 247.8 gas. These figures did
not vary significantly.
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Table 8.
Group
Data on veight gained after treatment and numbers and a statistical
estimate of the lengths of lumen larvae recovered froci a treated
group of chickens twenty-one days after infection.
•n i itti i m i inn m i ii in i h i
$ Chicken Hunber t
t t
J L
(Treated)
v/elght Increase t
r
Luaen larvae Recovered
After Beginning * Number t
of Treatment ((teio) i
Length
Total
i
Average t
978
979
980
961
993
998
1001
1005
1005
1011
1015
1014
1021
1025
1024
1027
1056
1040
1041
1049
1058
1062
1064
1067
1074
1081
1089
1092
1095
1099
1100
1102
1110
1116
1117
1124
1128
1151
1155
1159
1142
1149
1158
1160
1161 80
3516-
76,4
12
16
8
68
50
59
9
19
84
20
85
1
208
8
15
17
152
12
1
6
2
5
1
5
25
12
2
J49
3
I
g17
8
8
18
20
4
15
9
9
1
1084
^QQ ««
KTable 9* Data on weight gained after treatment of Group birds and a
Statistical estinate of the lengths of lutaen larvae recovered from
a control group
!
of chickens twenty-one days after infection.
Grot?) * Chicken Number t '.^lt Increase « Liraon Larvae Hecovered
i : After Beginning t Ifymber 1 Length
t : of Group C Treat- t I
t | nent (Gkus) t t
962 106 9
986* 120 1
967 118 14
999 95
1000 92 4
1002 85 14
1004 50 5
1012 74 5
1015 111 2
1017 104 2
1020 82 8
1025 91 130
1046 76 15
1054 78 18
1056 92 7
1065 108 9
1066 71
1075 73 6
1079 75 5
1066 16 73
6 1087 61 31
(Control) 1090 89 16
1101 70 72
1104 106 14
1105 73 7
1175 25 57
1109 79 2
1112 78 1
1115 60 5
1118 47 7
1119
I
11
1120 9
1121 88 3
1135 83 8
1154
1140
95 2
79 21
1141 101 4
1148 116 26
1150 84 11
1152 91
1162 71 15
1164 58 9
H65 103 9
1166 75 35
H67 66 5
1171 91 12
Totali 377<$ 697
Average t 82-08 35.1 1.4 em
controls
<
011 Oi £^I*OWtvii GVt?*Y6S ox en j-cK^sns JT6CGX v.
for eight consecutive days and their 1
Test 5
A ainglo dose of 0.05 ml of carbon disulfide was given each treated
bird In this test. Here, as in Test 4, only one treated and one control
group of chickens were used. Both were sacrificed twenty-one days post-
infection. Data showing numbers and lengths of vronns recovered and weight
increases in the host birds are presented in Tables 10 and 11 and Pig. 6,
The average nuabers of lumen larvae were 14.05 and 19«9t for Groups
and Df respectively. The difference betuoer these twe averages was not
significant.
Lumen larvae from Group C hosts averaged 1*5 cm in length, compared to
an average of 1.9 am in the Group D chickens. This difference was signi-
ficant at the 1 per cent level.
The terminal weights of Group C birds averaged 24j.p gns, and those of
Group D, 259.6 gas. Again, there was no significant difference between
these figures.
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T&ble 10. Data on weight gained after treatment and nuobers and a statistical
estinate of the lengths of luraen larvae recovered from a treated
group of chickens twenty-one days after infection.
Group » Chicken Nunber t Weight Increase t Lmon Larvae Recovered
t i After Treatment (Qms)* Bmber l Lonftih
976 89 25
984 64 1
985 80 14
991 44 27
996 62 24
1007 94 7
1008 68 17
1010 64 12
1016 78 15
1018 66 4
1038 91 18
1051 54 51
1055 92 2
1059 80 25
1045 69 1
1044 102 15
1047 74 9
1048 99 6
1C52 55 5
1055 65 6
C 1055 85 6
(Treated) 1071 55 8
1075 65 21
1076 68 9
1077 60 7
1085 86 58
1084 84 9
1088 84 14
1094 76 10
1098 65 9
1111 79 29
1114 78 4
1125 78 11
1150 68 5
1152 80 10
1145 109 7
1144 70 55
1155 109 50
1157 99 62.
1166 74 5
1169 66 12
1170 87 12
1172 69 5
1174 70 8
Total* 5588 618
Averages * 77.0 14.05 1.9 cm
Table 11. Data on weight gained after treatment of Group C birds and a statis-
tical estimate of the lengths of luaen larvae recovered from a
control group of chickens tvrenty-one days after infection.
Group : Chickon Number i Weight Increase t^
t t After Tr t s
t t of Group (One ) i
fatten Larvae Recovered
or t
J
Length
(Control)
977
968
969
990
992
995
991
1006*
1009
1022
1026
1029
10J0
1052
10^4
1057
1058
1045
1050
lO^l
IO59
1065
1072
1078
1080
1082
1065
1091
1093
1096
1097
1105
1106
1108
1125
1126
1127
1136
ll?7
1136
11%
1147
1153
1156
1159
H65
1173
4
5
31
82
8
1
3
1
15
19
5
23
2
139
19
6
d
30
5
30
1
14
22
Total* 3316
70f5
65
20
3*
35
,3
1
1
18
939
19.9 IrP «*
CD
2
o
M
g
IfU
130
roup C (Treated)
— Group D (Control)
i—!r ^ r
4 f ) h j. ifr
3UB5BQDSK:
controls.
:parison of rrowth curves of chickens receivin
i.oae of carbon disulfide and their untreated
mDISCUSSION
In this thesis, an attempt has boon made to demonstrate the effects of
several anthelmintics on the larval stages of the nematode Ascar
,
idia nalli
through the use of three quantitative criteria* a comparison of worm numbers,
•worm lengths, and host weight gains in infected, treated, versus correspond-
ing infected, untreated, groups of chickens. The general method of anthel-
mintic screening practiced here has also boen followed by Hansen ot al.
(1954c) and by other current workers. A known number of helminth eggs was
fed to laboratory animals, and by comparing the relative number of wora»
harbored by treated and untreated hosts at autopsy, the ebility of the test
substance to remove the worms in question vtos ascertained. Riedel (1950,
1951), Sloan et al. (1°5^)» and others have used a somewhat different ex-
perimental design to test anthelmintics in vivo when the host animals could
not be sacrificed for autopsy, or when an undetermined level of infection was
present. This procedure, however, required almost continuous observation of
the test animals in order that all fecal material which they passed could be
recovered and examined for worms. A comparison of the number of worms ex-
pelled by treated and untreated individuals was used as an indication of the
efficacy of the anthelmintic.
All data in this thesis was subjected to statistical analysis in order
that a uniform system might be followed for comparing results. The primary
tool used for analyzing data was the t-teet for group comparisons. Where the
value of t obtained from this process was on or close to a significant level,
a modified t-test using a square-root transformation* was also computed, as
^The use of this technique was suggested by Prof. Henry Tucker, Dept. of
Mathematics.
4?
a means of checking the original statistical results.
A new procedure for estimating worn lengths by the use of a statistical
•sapling technique was followed throughout the course of the study, This
method was based on an analysis of variance comparing the differences in
lengths of worms found (a) within randomly selected chickens, and the varia-
tion existing (b) between the lengths of worms from one chicken and those
from other chickens. The F ratio obtained from this analysis indicated that
there was no statistically significant variation between lengths of worms re-
covered from any one bird and those taken from any other randomly chosen
birds. Therefore, a sampling procedure was devised for estimating average
worm length, based on the assumption that the lengths of worms taken from a
few birds selected by chance from each group would furnish an accurate esti-
mate of the average lengths of all the A. galll found within all the chickens
from that particular group. Measurements v<*ere taken of all the worms from a
ssmple of 10 per cent of the total number of birds from each group. The
relationship between anthelmintic treatment and worm length, as evidenced by
the experimental results of this study, appears to be uncertain.
Statistical analysis of both the data concerning worm number and terminal
xfeighta in Groups C and D of Test 5 indicated that the anthelmintic tended to
be effective in removing lumen larvae under the conditions in which it was
used, and that either this reduction in worm burden or some other factor re-
sulted in a definitely recognizable weight advantage in the treated birds as
compared to the untreated group. It would be very difficult, however, to
establish a definite correlation between numbers of lumen larvae and amount
of weight gained. Chicken #668, which made the third greatest weight gain
(109 gms) of any bird in the group, had the heaviest Ascarldia infection, 29
worms. Chicken #68J, whioh made the third smallest weight increase after
Mtreatment, contained only 4 worms, much less than the average group Infection
rate of 7»5 worms. On the other hand, Chicken #912, which showed a weight
gain equal to that of bird $882» contained 2^ larval aeearids, or nore than
three tines as many woraa as a bird which showed an equal weight increase.
In Groin D in Test 2, the average number of luacn larvao recovered per
bird was 17»1* couplod with an average weight gain of 66,5 gas. Of the
7 birds which were infected with more than the mean number of worms, 6 made
less than the average weight increase. In this group, the chicken with the
heaviest worm infection (60) nade a wight gain only 0,5 gP less than the
average increase of 66.5 fFia, Of the 10 birds whose weight gains exceeded
the average, 8 had less -than the average worm burden for the group.
Since it appears doubtful, in the light of these data, that the nearly
significant weight increase that the Test p* treated birds established over
their eontrols was due directly to the quantitative severity of their worm
infection, tho source of this variation remains to be explained. One possi-
bility is that the chemical constituents of the Caricide acted as a growth
stimulant in the treated birds, independent of any anthelmintic activity it
might have had. Another explanation mi$it be that tho continual presence of
the drug in the intestine of the treated birds (the digestive tract of
chickens which have food available is never entirely empty) acted in some
way to disrupt or to completely prevent the entrance of the larvae into the
tissues, which lias been definitely defined as the time at which the greatest
weight looses occurred in the test chickens in the experiments of other
workers.
In this connection, an analysis of the data concerning the number of
days post infection at which tissue phase larvae were recovered, in the first
three tests, suggested a negative answer to this question. The peak of the
*5
tissue phase, i.e., the day on which the greatest number of worms were re-
covered from the intestinal walls by the digestion process, was eleven days
post infection for both treated and control groups in Test 1, day 1J for
both treated and control birds in Test 2, and day 12 post infection for both
treated and control groups in Test J, Thus, the presence of the drug ap-
peared to have no influence, in either suppressing or accelerating the migra-
tory cyole of the Ascoridia larvae in these tests.
Another possible indirect influence of anthelmintic treatment on the host
which may have resulted in, or at least contributed to* the nearly significant
weight gains demonstrated by treated Group C in Test % could be explained in
the following manner. The presence of certain bacteria and/or protozoa in
the alimentary tract of normal chickens could conceivably result in the re-
lease by these micro-organisms of toxic metabolic products which are regularly
absorbed by the host. The action of the test drug may have destroyed these
organisms, and thus contributed incidentally to the bird's v:ell~being by re-
moving the source of these toxic substances, which had been acting as a "drag"
on the animal prior to the time of treatment. The treated host was then able
to expend the extra energy, which formerly had been sidetracked, for its own
anabolic procosces. Todd and Hansen (1951 ) have postulated a similar theory
in attempting to explain the commonly observed situation in vdiich chickens
with light worm infeotions often gained the least weight during experiments.
They believed that the failure of these birds to make normal weight gains was
due to the portion of their total energy expenditure which was lost in com-
batting their parasites. This explanation also may serve to clarify some of
the disproportionate-appearing results which were cited in preceding sections
of this discussion.
The end of the tissue phase cycle as indicated by the last day after
H6
infection on which tissue phase larvae were present coincides in general with
the stages of the cycle as described by Tugwell one Ackert (1952)« They
stated that the tissue phase was most prominent from the tenth to the seven-
teenth day after infection, but that it extended to the twenty-third day.
The data from the present expeririente show that in Test 1, the last mucosa
larva was recovered on day 15 post infection in the treated birds, and on
day 18 in the control. In Toot 2, the last nucosa larvae were found on dayg
19 and 18 in the treated and control groups, respectively, and in Tost J, the
last tissue larvae in Group A were present on day 18, and in the Group B birds,
on day 19. Thus, tho indication is that the end of the tissue phase is not
influenced to any extent by the treatment schedules followed in the three
Oaricide tests. This consideration of the apparent influence of Caricide
treatment on the tissue cycle has been included because the effects of the
migratory stage on the health of the host are so pronounced. The addition to
the feed of a drug which might be effective against adult Ascaridia might not
only be xuselesa for removing the larval stages, but couid actually result in
aore than nor.ml damage to young birds by tho creation of a semi-toxic en-
vironment in tho intestinal lumen, thereby influencing the larvae to migrate
into the mucosa at an oarlicr than norial date. In addition, the drug might
also influence them to delay their return to the lumen. However, since the
migratory cycle does not seem to be influenced by Oaricide, these possibilities
are irrelevant in an evaluation of the activity of Oaricide as used in the work
described hero.
In Tost J| carbon disulfide vat chosen as the anthelmintic to test the
action of a fumigant-typo compound on the tissue phase larvae. This experi-
ment seemed pertinent at this time because of the overall lack of activity
against larval forma demonstrated by Caricide, in which active prinoiple was
*T
not a funigant. The inaccessibility of the mucosa larvae to the toxie action
of an alkaloid te the form of nicotine was reported by Hansen et al. (1954c).
The funigating action of carbon disulfide also proved to be ineffective in
removing larval ascarids in a 1-dose treatment,
A resucio of the experimental results contained in this thesis Indicate,
therefore, that while Compound 180-C and carbon disulfide were not applicable,
in the dosages used, as anthelmintics to combat the tissue phase of the
Ascaridja life cycle, further investigation on the effects of continuous
low-level Oarlcide treatment for this parasite is necessary before a final
decision can bo made on its applicability to A, fffilli infections in chickens.
At tho present time, a repetition of Test 5 is being conducted to attempt to
resolve these questions.
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SlfosiAMT
A series of five laboratory experiments Involving approximately 420
chickens have been conducted to evaluate the effects of three anthelmintics
on the lumen and tissue phase larvae of Ascari&ja palli, the large roundworm
of chickens. All birds used in this study were infected with 100 10 or
75 +_ 5 embryonated A_, fiftlljl ova. In Teste 1 , 2, and 3, the experimental birds
were divided into four groups. Groups A (treated) and B (control) were fur-
ther subdivided Into groups of two birds each, which v:ere slaughtered at con-
secutive intervale during the progression of the tissue phase of the Aacarjd^
life cycle. Groups C (treated) and D (control) vers killed 21 days after in-
fection. In Tests 4 and 5» all birds were killed 55 days post infection.
In Te3t 1, a single 25 mgm dose of Oaricide (1-diethylcarbamyl-A-methyl-
piperaaine dihydrogen citrate) had no statistically detectable effects on ei-
ther the number of lumen or tissue phase larvae, or on the growth of the host
birds.
In Test 2, 12,5 mgn of Oaricide given to the treated birds for eight con-
secutive days had no appreciable effects on either host weight or numbers of
lumen or tissue phase larvae,
A continuous daily low level dosage of Oaricide (approximately 12,5 mga
per bird per day) added to the feed of the treated groups in Test 5 resulted
in a nearly statistically significant reduction in numbers of lumen larvae in
the Group C chickens. In addition, the average weight gains of these birds
were significantly greater than those of the corresponding control group,
A daily dosage of 25 mgm of Compound 180-C (l-carbethoxy-4-ciethyl
piperazine hydrochloride) for eight consecutive days had no significant
effect on either worm number or host weight.
49
k single 0,05 ml dose of carbon disulfide was ineffective in influencing
either host worn populatione or weight increases.
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The gcanonic import of the larval migratory phase in the life cycle
of Aacarldia aalli, the large roundworm of fowls, has been suggested by
various workers. iThile control of the adult stage of this nematode has
been achieved through anthelmintic medication, treatment of the tissue-
penetrating phase with existing drugs has been unsuccessful.
A new approach to this problem was suggested by the recent appearance
of ocveral newly synthesized piperazine compounds which have shown consid-
erable promise in the treatment of filariasls and ascariasio in man, and
for certain parasitic infections in animals.
The c;rporiacntal design utilized throughout the course of this study
involved the testing of the effects produced by two piperazine derivatives
and carbon -Usuifide on parasitic infections in laboratory animals. £hite
Rock and New Hampshire chickens were used exclusively as test animals. They
were obtained as day old birds from a commercial source. At fourteen days
of age, each bird received a known number (either 100 ^+ 10 or 75 ^+ 5) of
embryonated Ascaridia galil ova.
A total of five tests were performed, utilizing 420 chickens. In the
first three experiments, the chickens were divided into four groups. Groups
A and C received a predetermined dosage of the test anthelmintic* while Groups
8 and D were maintained as parasitized but untreated controls. Beginning on
the eleventh day after infection, and continuing for ten days thereafter,
two Group A and two Group B birds were killed for autopsy every 24 hours.
On the twenty-first day after infeotion, all Group C and Group D birds were
also killed and examined. In Tests 4 and % only the experimental groups
C and D were used.
HM present in the lumen of the intestine of each chicken were
collected by flushing a stream of water through tho gut. In addition, the
intestine: of all Group A and B birds were subjected to an artificial diges-
tion process to remove the tissue-penetrating larvae that were imbedded in
tho intestinal wall.
As criteria of the effect of the anthelnintic being tested, comparisons
were mde between numbers and lengths of luuen larvae (in Groups C and D),
and numbers of both lumon arid tissue phase larvae and lengths of lumen
larvae (in Groups A and B) recovered from a parasitised treated group of
chickens and its corresponding parasitised untreated control. In addition,
daily weight recorue of all Group C and D chickens were kept from the date of
treatment until they were slaughtered for autopsy. All data were statisti-
cally analyzed to determine significance. Results were as follows!
1, In Test 1, a single 2? nga oral dose of Oarielde (1-dioth: Icarbamyl-
A-aethylplperaaine dihydrogen citrate) did not significantly reduce the
number of either lumen or ticsue phase larvae in Group A birds,
2, This treatment, or some other factor, did significantly reduce the
length of the lumen larvae from Group A birds,
% Ho significant variation was found between either number* or lengths
of lumen larvae, or weight of the host birds, in Groups and D,
4, In Test 2, an oral dose of 12,5 mgm of Caricide per bird for eight
consecutive days did not sigiifioantly reduce the number of either tissue
phase or lumen larvae in Group A, or tho number of lumen larvae in Group 0.
% Ho significant variation was found between weights of Group C and
D chickens,
6. Worms recovered from both Group A and Group C were significantly
longer than those present in the corresponding control birds,
7, In Test % a continuous daily low-level dosage of Oarielde at the
rate of approximately 12.5 mgo per bird por day did not significantly reduce
numbers of oither ticstje phase or lumen larvae in Groups A or C.
ft. Tho average weight gains exhibited by Group G chickens in Test 2
were an the borderline of being significantly greater than those of their
control group (Group D).
©. An oral dosage of 25 ago of Compound 180-C (l-carbethoxy-4-methyl-
piperasinc hydrochloride) per bird ^ar day, for eight consecutive days, did
not produce any significant variation in worn numbers, or in weight of the
treated chickens, in Test 4,
10, A single oral cone of 0.05 ml of carbon disulfide was ineffective
in ir.fluer.cin r host worm populations or weight increase*.
